WHO, UN Foundation, partners launch first-of-its-kind COVID-19 Solidarity Response Fund

▴ WHO UN Foundation partners launch first-of-itskind COVID 19 Solidarity Response Fund
All donations made to the United Nations Foundation and Swiss Philanthropy Foundation are tax-deductible to the extent allowable by the law, where applicable (U.S. and Switzerland). Additionally, Swiss Philanthropy Foundation has partnered with Transnational Giving Europe to extend tax benefit to ce

 A new coronavirus disease (COVID-19) Solidarity Response Fund will raise money from a wide range of donors to support the work of the World Health Organisation (WHO) and partners to help countries respond to the COVID-19 pandemic.

The fund, the first-of-its-kind, enables private individuals, corporations and institutions anywhere in the world to come together to directly contribute to global response efforts, and has been created by the United Nations Foundation and the Swiss Philanthropy Foundation, together with WHO.

"We are at a critical point in the global response to COVID-19 – we need everyone to get involved in this massive effort to keep the world safe," said Dr. Tedros Adhanom Ghebreyesus, WHO Director-General. "We are immensely grateful to the UN Foundation and the Swiss Philanthropy Foundation for coming forward to help us set up this fund. A lot of people and institutions have been saying they want to contribute to the fight against the novel coronavirus. Now they can."

The fund launches with major support already lined up, including from Facebook and Google who have instituted a matching scheme for funds raised through their platforms, while individual donors are also supporting the fund through www.COVID19ResponseFund.org.

"We can’t ignore the fact that this is a truly global problem – one that requires truly global solutions," said Elizabeth Cousens, UN Foundation President and CEO. "The case for global cooperation could not be clearer – communities everywhere are affected, and people want to contribute. This new fund will create space for people everywhere, together, to fight this virus."

Funds will go towards actions outlined in the COVID-19 Strategic Preparedness and Response Plan to enable all countries – particularly those most vulnerable and at-risk, and with the weakest health systems – to prepare for and respond to the COVID-19 crisis including rapidly detecting cases, stopping transmission of the virus, and caring for those affected.

WHO and its partners are seeking financing for protective equipment for frontline health workers; to equip diagnostic laboratories; improve surveillance and data collection; establish and maintain intensive care units; strengthen supply chains; accelerate research and development of vaccines and therapeutics; and take other critical steps to scale up the public health response to the pandemic.

The COVID-19 Solidarity Response Fund is hosted by two foundations, the UN Foundation (registered in the United States) and the Swiss Philanthropy Foundation (registered in Switzerland). Both foundations have established relationships with the World Health Organization, allowing for efficient transfer of financial resources to enable COVID-19 response efforts.

Apart from giving online at www.COVID19ResponseFund.org, the UN Foundation can also receive donations via check or wire from around the world by contacting COVID19Fund@unfoundation.org.

All donations made to the United Nations Foundation and Swiss Philanthropy Foundation are tax-deductible to the extent allowable by the law, where applicable (U.S. and Switzerland). Additionally, Swiss Philanthropy Foundation has partnered with Transnational Giving Europe to extend tax benefit to certain additional European countries where applicable.

WAM/Hatem Mohamed

Tags : #Who #Emergencyresponsefund #Covid19

About the Author


Team Medicircle

Related Stories

18 Jun

FDA approves nasal antihistamine for nonprescription use

Seasonal allergies affect millions causing nasal congestion, runny nose and sneezing. Approval of Asteopro (Azelastine Hydrochloride nasal spray 0.15%) can help many patients with allergies.

View
23 Dec

Glenmark collaborates with Menarini for commercializing Ryaltris nasal spray across Europe

The licensing agreement will be effective in 33 countries throughout the European region including France, Italy, and Spain

View
18 Dec

Research on preventative nasal spray, which protects against COVID-19 and common cold, published in leading peer-reviewed academic journals

Research on a novel nasal spray therapy, INNA-051, which has been shown to reduce COVID-19 viral replication by up to 96 percent in a gold standard ferret study, has been published in two leading international peer-reviewed journals.

View
07 Oct

Glenmark Pharmaceuticals receives ANDA approval for Dimethyl Fumarate Delayed-Release Capsules

Glenmark Pharmaceuticals Inc., USA has been granted final approval by the U.S. FDA for Dimethyl Fumarate DR Capsules, the generic version of Tecfidera

View
18 Aug

Glenmark appoints Dipankar Bhattacharjee to its Board of Directors

Glenmark Pharmaceuticals announced the appointment of Mr Dipankar Bhattacharjee as Independent Non-Executive Director on the Board of the organization

View
30 Jul

Food Allergies: All that you have to know

Skin prick testing can in some cases produce bogus negative or bogus positive outcomes.

View
21 May

Cipla receives final approval for Migranal

Cipla receives final approval for generic version of Migranal (Dihydroergotamine Mesylate Nasal Spray) with a Competitive Generic Therapy Designation

View
12 May

Hikma Announces the Launch of Propofol Injectable Emulsion, USP

Hikma responds to COVID-19 shortage with launch of Propofol Injectable Emulsion, USP. Sedative for patients on ventilators currently in short supply in the US

View
28 Feb

Glenmark Pharma Signs an Exclusive Licensing Agreement with Hikma Pharmaceuticals

Under the terms of the agreement, Glenmark will be responsible for the continued development and regulatory approval of Ryaltrisâ„¢ by the US FDA, while Hikma will be responsible for the commercialization of Ryaltrisâ„¢ in the US.

View

-Advertisements-




Trending Now

The Digital Sleep Thief: How Night-time Screen Addiction is Robbing You of Bed-time RestApril 02, 2025
KKR Launches ‘Knight Bite’ – A Digital Series That Serves Up Food, Fun, and Cricket!April 02, 2025
Crompton rolls out its all new range of Aura, Avancer & Jedi Air Coolers for an effortless summer cooling experienceApril 02, 2025
CARE Hospitals, Hi-Tech City Strengthens Orthopaedics Department with Renowned SurgeonsApril 02, 2025
World Autism Awareness Day: Breaking the Chains of Stigma in IndiaApril 02, 2025
From Scroll to Squint: How Reels Are Reshaping Your VisionApril 02, 2025
Moscow Center for Diagnostics and Telemedicine Receives License for Radiology Residency ProgramApril 02, 2025
CARE Hospitals Launches AI-Powered Non-Invasive Therapy – An innovative modality introduced in Telangana & Andhra PradeshApril 02, 2025
High-Rise Heart Attacks: Are Skyscrapers Turning Survival into a Race Against Time?April 02, 2025
DCDC’s $150 Crore Expansion: Can Innovative Clinics End India's Kidney Crisis?April 02, 2025
Medanta Rolls Out ‘Colon Tunnel on Wheels’ to Drive Awareness on Colorectal Cancer Prevention & Early DetectionApril 01, 2025
Zigly launches 2 pet hospitals, opens 4 new stores; expects ARR to more than double in 1-2 yearsApril 01, 2025
University of Leeds Announces International Masters Regional Scholarships for 2025April 01, 2025
Avantor Recognized with Two Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2025April 01, 2025
Foundation Stone Laid for Madhav Netralaya Eye Hospital & Research CentreApril 01, 2025
Doomscrolling at Midnight: How Indians Are Sacrificing Sleep for ScreensMarch 31, 2025
Essential Medicines Price Surge: Are Patients Paying the Price?March 31, 2025
Prioritize your health during the holy days of RamzanMarch 31, 2025
Tired of Stomach Cramps? These Simple Foods Can Heal Your GutMarch 31, 2025
Regional growth booming for startups in 2024 - QBO Innovation studyMarch 31, 2025